REGMF (RemeGen Co) Preferred Dividends : $0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is RemeGen Co Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. RemeGen Co's preferred dividends for the six months ended in Dec. 2024 was $0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $0.0 Mil.

RemeGen Co Preferred Dividends Historical Data

The historical data trend for RemeGen Co's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RemeGen Co Preferred Dividends Chart

RemeGen Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Preferred Dividends

Get a 7-Day Free Trial

RemeGen Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Preferred Dividends	Get a 7-Day Free Trial								-	-	-	-	-

RemeGen Co Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

RemeGen Co (OTCPK:REGMF) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

RemeGen Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (OTCPK:REGMF) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

09995:Hong Kong REG:Germany 688331:China

Address

58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN

Website

https://www.remegen.com

RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat major diseases such as autoimmune diseases, oncology, and ophthalmology. The company has its operations in China and the USA and derives the majority of its revenue from China.